PR

Parth Ramjibhai Savaliya

Active Director Director DIN 11422147
DIN 11422147 First appointment Dec 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Dec 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Parth Ramjibhai Savaliya

Data last updated:

Parth Ramjibhai Savaliya is a Director at Nexurion Pharma Private Limited (since 2026) and Designated Partner at Regis Projects Llp (since 2025).

DIN 11422147
Primary Designation Director
First Appointment 11 Dec 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nexurion Pharma Private Limited U21000GJ2026PTC183747
Director16 Sep 20262026Active
Designated Partner11 Dec 20252025Active

Directorship timeline

Open interactive timeline →
Regis Projects Llp
Nexurion Pharma Private Limited
Premium access

Shareholding and investment profile for Parth Ramjibhai Savaliya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Parth Ramjibhai Savaliya

Parth Ramjibhai Savaliya currently holds 2 directorships: Nexurion Pharma Private Limited (Director, since 16 Sep 2026); Regis Projects Llp (Designated Partner, since 11 Dec 2025).

Parth Ramjibhai Savaliya was first appointed on 11 Dec 2025 as Designated Partner at Regis Projects Llp. The most recent appointment on record is 16 Sep 2026 at Nexurion Pharma Private Limited.

The current boards of Parth Ramjibhai Savaliya's companies include Darshil Anilbhai Kathiriya (Nexurion Pharma Private Limited), Krunal Kirtikumar Shah (Nexurion Pharma Private Limited), Mayur Ashokbhai Kikani (Nexurion Pharma Private Limited), Vivek Shantilal Langnecha (Nexurion Pharma Private Limited), Aum Lakkad (Regis Projects Llp), Bhargav Patel (Regis Projects Llp), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available